tiprankstipranks
Trending News
More News >
MiMedx Group Inc. (MDXG)
:MDXG
US Market

MiMedx Group (MDXG) Stock Statistics & Valuation Metrics

Compare
368 Followers

Total Valuation

MiMedx Group has a market cap or net worth of $1.06B. The enterprise value is $1.36B.
Market Cap$1.06B
Enterprise Value$1.36B

Share Statistics

MiMedx Group has 147.37M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding147.37M
Owened by Insiders1.95%
Owened by Instutions34.72%

Financial Efficiency

MiMedx Group’s return on equity (ROE) is 0.22 and return on invested capital (ROIC) is 19.67%.
Return on Equity (ROE)21.97%
Return on Assets (ROA)16.07%
Return on Invested Capital (ROIC)19.67%
Return on Capital Employed (ROCE)26.96%
Revenue Per Employee$416,821.983
Profits Per Employee$50,679.809
Employee Count837
Asset Turnover1.32
Inventory Turnover2.52

Valuation Ratios

The current PE Ratio of MiMedx Group is 33.33. MiMedx Group’s PEG ratio is -0.84.
PE Ratio33.33
PS Ratio4.05
PB Ratio7.32
Price to Fair Value7.32
Price to FCF21.92
Price to Operating Cash Flow21.36
PEG Ratio-0.84

Income Statement

In the last 12 months, MiMedx Group had revenue of $348.88M and earned $42.42M in profits. Earnings per share was $0.29.
Revenue$348.88M
Gross Profit$288.43M
Operating Income$58.92M
Pretax Income$57.29M
Net Income$42.42M
EBITDA60.69M
Earnings Per Share (EPS)0.29

Cash Flow

In the last 12 months, operating cash flow was $67.13M and capital expenditures $0.00, giving a free cash flow of $67.13M billion.
Operating Cash Flow$67.13M
Free Cash Flow$67.13M
Free Cash Flow per Share$0.46

Dividends & Yields

MiMedx Group pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield4.56%
Earnings Yield3.00%

Stock Price Statistics

Beta0.81
52-Week Price Change6.21%
50-Day Moving Average7.92
200-Day Moving Average7.54
Relative Strength Index (RSI)36.84
Average Volume (3m)603.21K

Important Dates

MiMedx Group upcoming earnings date is May 6, 2025, After Close.
Last Earnings DateFeb 26, 2025
Next Earnings DateMay 6, 2025
Ex-Dividend Date

Financial Position

MiMedx Group as a current ratio of 4.21, with Debt / Equity ratio of <0.01
Current Ratio4.21
Quick Ratio3.69
Debt to Market Cap<0.01
Net Debt to EBITDA-1.61
Interest Coverage Ratio58.51

Taxes

In the past 12 months, MiMedx Group has paid $15.29M in taxes.
Income Tax$15.29M
Effective Tax Rate26.70%

Enterprise Valuation

MiMedx Group EV to EBITDA ratio is 20.37, with an EV/FCF ratio of 20.31.
EV to Sales3.76
EV to EBITDA20.37
EV to Free Cash Flow20.31
EV to Operating Cash Flow19.80

Balance Sheet

MiMedx Group has $104.42M in cash and marketable securities with $1.00M in debt, giving a net cash position of -$103.42M billion.
Cash & Marketable Securities$104.42M
Total Debt$1.00M
Net Cash-$103.42M
Net Cash Per Share-$0.70
Tangible Book Value Per Share$1.10

Margins

Gross margin is 82.78%, with operating margin of 16.87%, and net profit margin of 12.16%.
Gross Margin82.78%
Operating Margin16.87%
Pretax Margin16.42%
Net Profit Margin12.16%
EBITDA Margin18.44%
EBIT Margin16.71%

Analyst Forecast

The average price target for MiMedx Group is $12.50, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$12.50
Price Target Upside82.22%
Analyst ConsensusStrong Buy
Analyst Count4
Revenue Growth Forecast8.52%
EPS Growth Forecast-32.91%

Scores

Smart Score4
AI Score67
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis